<DOC>
	<DOCNO>NCT02882854</DOCNO>
	<brief_summary>Postoperative nausea vomiting ( PONV ) pain common cause Post Anesthesia Care Unit ( PACU ) discharge delay , untreated PONV occur 20-30 % post-surgical patient . The effect guanfacine ( GF ) administration pain nausea score assess two group . One group receive 1 mg GF take orally group receive similar appear placebo ( contain drug ) take orally .</brief_summary>
	<brief_title>Guanfacine PONV Pain After Sinus Surgery</brief_title>
	<detailed_description>Pain surgery commonly treat narcotic potentiate PONV , delay PACU discharge . In multiple study , alpha-2 agonist clonidine dexmedetomidine reduce incidence PONV post-op pain , well requirement postoperative analgesic . These action mediate via central alpha-2A receptor ( A2AR ) . Of A2AR agonist , guanfacine , though weak antihypertensive agent , high selectivity A2AR , date untested potential treat either PONV post-operative pain .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>VUMC patient undergo sinus surgery MCE OR Inability read freely consent Patients take alpha2 agonist routinely ( guanfacine , clonidine , tizanidine ) Patients undergo sinus surgery plan great 3 hour Patients significant preexist pain , chronic pain ( opioid , methadone ) therapy , severe fibromyalgia preexist pain condition body part Patients preoperative nausea/vomiting baseline . Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>